Drugs News and Research

RSS

AI-powered drug discovery offers hope for cystinosis patients

Artificial intelligence is becoming increasingly important in drug discovery. Advances in the use of Big Data, learning algorithms and powerful computers have now enabled researchers at the University of Zurich (UZH) to better understand a serious metabolic disease.

14 Jul 2023

Australian researchers discover how COVID-19 can infect the human placenta

In a landmark study published in Nature Cell Biology, Australian researchers, led by Professor Jose Polo from Monash University and the University of Adelaide and University of Melbourne's Professor Kanta Subbarao from the Peter Doherty Institute for Infection and Immunity (Doherty Institute), have revealed how COVID-19 can infect the human placenta.

14 Jul 2023

Scientists discover new mechanism for kidney cell renewal

University of Texas at Dallas scientists have discovered a previously unknown "housekeeping" process in kidney cells that ejects unwanted content, resulting in cells that rejuvenate themselves and remain functioning and healthy.

14 Jul 2023

New biomarker could track progression of Alzheimer's disease

Two pathologies drive the progression of Alzheimer's disease. Early on, amyloid beta plaques lead the way, but around the time cognitive symptoms arise, tau tangles take over as the driving force and cognition steadily declines.

13 Jul 2023

New mobile app aims to bridge the gap in communication for people with ASD

Researchers from the Universitat Oberta de Catalunya (UOC) and Parc Taulí University Hospital have developed a mobile application that compiles and presents valuable pieces of information and advice for people who interact with children or adults with autism spectrum disorder (ASD).

13 Jul 2023

British neuroscientist wins Hartwig Piepenbrock-DZNE Prize for contributions to dementia research

This year's "Hartwig Piepenbrock-DZNE Prize", endowed with 60,000 euros, goes to the British neuroscientist Alison Goate, DPhil. The award recognizes her outstanding contributions to research into Alzheimer's disease and frontotemporal dementia.

13 Jul 2023

New precision medicine trial shows promise for treating rare brain tumors

Papillary craniopharyngiomas (PCPs) are a rare type of brain tumor that cause substantial morbidity for patients.

13 Jul 2023

Wait, What’s a PBM?

Pharmacy benefit managers, or PBMs, are intermediary companies that negotiate the price of prescription drugs.

13 Jul 2023

Evotec and Bristol Myers Squibb enter licence agreement within neuroscience partnership

Evotec SE today announced that Bristol Myers Squibb Company has exercised its option to enter into an exclusive global licence agreement.

From Evotec 13 Jul 2023

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

Researchers used a K18-hACE2 transgenic (ACE2.Tg) mouse model to demonstrate that interleukin-9 (IL-9).

13 Jul 2023

UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

Researchers at the UCLA Jonsson Comprehensive Cancer Center have confirmed that a large number of genetic variants of unknown significance are in fact verified mutations that predispose patients to a rare hereditary syndrome that increases the risk of kidney cancer.

13 Jul 2023

Study shows potential for treating ALS with two existing drugs

New research suggests that targeting autoimmune inflammation associated with amyotrophic lateral sclerosis (ALS) using two drugs, one of them already approved for multiple sclerosis, could be a promising approach for treatment.

12 Jul 2023

New heart cell atlas reveals detailed structure of the human heart

In a new study, published today (12 July) in Nature, researchers have produced the most detailed and comprehensive human Heart Cell Atlas to date, including the specialised tissue of the cardiac conduction system - where the heartbeat originates.

12 Jul 2023

Study provides a transformational new insight into emergence of antimicrobial resistance

A research study led by the University of Oxford provides a transformational new insight into how antimicrobial resistance (AMR) emerges in patients with bacterial infections.

12 Jul 2023

Mitochondrial impairment, not inflammation, may be main driver of Gulf War Illness symptoms

Gulf War Illness (GWI) is a chronic multisymptom health condition affecting one-third of all veterans who served in the 1991 Gulf War, most of whom remain afflicted more than 30 years later.

12 Jul 2023

Researchers find new way to target leprosy infection

Leprosy has existed since at least Biblical times, yet scientists still don't know exactly how Mycobacterium leprae causes the disease's symptoms.

12 Jul 2023

Scientists identify signal essential for blood-brain barrier formation

What makes the vital layer of protective cells around the brain and spinal cord - the blood-brain barrier - more or less permeable has been one of the more mystifying questions in neuroscience.

12 Jul 2023

Psychedelic-based therapies poised to change the treatments for patients with PTSD

Psychedelic-based therapies are poised to change the treatments that psychiatrists can offer patients.

12 Jul 2023

Biomimetic nanocarriers fuse with cell membranes to deliver drugs

In drug delivery, the therapeutic behavior of the nanocarriers is limited by the "foreign" character of their surface.

12 Jul 2023

Does previous antibiotic treatment affect COVID-19 severity?

Researchers determine whether frequent antibiotic use increased the risk of adverse outcomes, including death, following SARS-CoV-2 infection.

12 Jul 2023

Drugs News and Research

AI-powered drug discovery offers hope for cystinosis patients

Australian researchers discover how COVID-19 can infect the human placenta

Scientists discover new mechanism for kidney cell renewal

New biomarker could track progression of Alzheimer's disease

New mobile app aims to bridge the gap in communication for people with ASD

British neuroscientist wins Hartwig Piepenbrock-DZNE Prize for contributions to dementia research

New precision medicine trial shows promise for treating rare brain tumors

Wait, What’s a PBM?

Evotec and Bristol Myers Squibb enter licence agreement within neuroscience partnership

IL-9 identified as contributor to viral spread and airway inflammation in COVID-19

UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

Study shows potential for treating ALS with two existing drugs

New heart cell atlas reveals detailed structure of the human heart

Study provides a transformational new insight into emergence of antimicrobial resistance

Mitochondrial impairment, not inflammation, may be main driver of Gulf War Illness symptoms

Researchers find new way to target leprosy infection

Scientists identify signal essential for blood-brain barrier formation

Psychedelic-based therapies poised to change the treatments for patients with PTSD

Biomimetic nanocarriers fuse with cell membranes to deliver drugs

Does previous antibiotic treatment affect COVID-19 severity?

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News